Published in Cancer Gene Ther on March 01, 2002
Lymphocyte display: a novel antibody selection platform based on T cell activation. PLoS One (2009) 0.88
Immune Tolerance Induction against Experimental Autoimmune Encephalomyelitis (EAE) Using A New PLP-B7AP Conjugate that Simultaneously Targets B7/CD28 Costimulatory Signal and TCR/MHC-II Signal. J Mult Scler (Foster City) (2015) 0.77
Balanced secretion of anti-CEA x anti-CD3 diabody chains using the 2A self-cleaving peptide maximizes diabody assembly and tumor-specific cytotoxicity. Gene Ther (2017) 0.75
Synthetic genetic polymers capable of heredity and evolution. Science (2012) 3.59
Ribozyme-catalyzed transcription of an active ribozyme. Science (2011) 3.42
Full activation of PKB/Akt in response to insulin or ionizing radiation is mediated through ATM. J Biol Chem (2004) 2.33
Molecular breeding of polymerases for amplification of ancient DNA. Nat Biotechnol (2007) 1.63
In-ice evolution of RNA polymerase ribozyme activity. Nat Chem (2013) 1.52
Tumor antigen-specific induction of transcriptionally targeted retroviral vectors from chimeric immune receptor-modified T cells. Nat Biotechnol (2002) 1.48
CARbodies: Human Antibodies Against Cell Surface Tumor Antigens Selected From Repertoires Displayed on T Cell Chimeric Antigen Receptors. Mol Ther Nucleic Acids (2013) 1.45
Generic expansion of the substrate spectrum of a DNA polymerase by directed evolution. Nat Biotechnol (2004) 1.34
Multivalent antibodies: when design surpasses evolution. Trends Biotechnol (2010) 1.28
Ice as a protocellular medium for RNA replication. Nat Commun (2010) 1.18
Antibody engineering: facing new challenges in cancer therapy. Acta Pharmacol Sin (2005) 1.14
Directed evolution of DNA polymerase, RNA polymerase and reverse transcriptase activity in a single polypeptide. J Mol Biol (2006) 1.12
In vivo tumor targeting and imaging with engineered trivalent antibody fragments containing collagen-derived sequences. PLoS One (2009) 1.02
Cells as vehicles for cancer gene therapy: the missing link between targeted vectors and systemic delivery? Hum Gene Ther (2002) 1.00
Antibodies and gene therapy: teaching old 'magic bullets' new tricks. Trends Immunol (2004) 0.99
A short adaptive path from DNA to RNA polymerases. Proc Natl Acad Sci U S A (2012) 0.98
Selection of functional human antibodies from retroviral display libraries. Nucleic Acids Res (2005) 0.97
A novel emulsion mixture for in vitro compartmentalization of transcription and translation in the rabbit reticulocyte system. Protein Eng Des Sel (2004) 0.97
Evolving a polymerase for hydrophobic base analogues. J Am Chem Soc (2009) 0.95
CyDNA: synthesis and replication of highly Cy-dye substituted DNA by an evolved polymerase. J Am Chem Soc (2010) 0.95
A novel cell binding site in the coiled-coil domain of laminin involved in capillary morphogenesis. EMBO J (2003) 0.94
The multicompartmental p32/gClqR as a new target for antibody-based tumor targeting strategies. J Biol Chem (2010) 0.94
Induction of human T lymphocyte cytotoxicity and inhibition of tumor growth by tumor-specific diabody-based molecules secreted from gene-modified bystander cells. J Immunol (2003) 0.94
Molecular breeding of polymerases for resistance to environmental inhibitors. Nucleic Acids Res (2011) 0.93
Enhanced antiangiogenic therapy with antibody-collagen XVIII NC1 domain fusion proteins engineered to exploit matrix remodeling events. Int J Cancer (2006) 0.92
Polymerase engineering: towards the encoded synthesis of unnatural biopolymers. Chem Commun (Camb) (2009) 0.92
The XNA world: progress towards replication and evolution of synthetic genetic polymers. Curr Opin Chem Biol (2012) 0.92
Chronic gene delivery of interferon-inducible protein 10 through replication-competent retrovirus vectors suppresses tumor growth. Cancer Gene Ther (2005) 0.91
Functional improvement of antibody fragments using a novel phage coat protein III fusion system. Biochem Biophys Res Commun (2002) 0.90
Proteasome activator complex PA28 identified as an accessible target in prostate cancer by in vivo selection of human antibodies. Proc Natl Acad Sci U S A (2013) 0.90
Compartmentalized self-replication: a novel method for the directed evolution of polymerases and other enzymes. Methods Mol Biol (2007) 0.88
Lymphocyte display: a novel antibody selection platform based on T cell activation. PLoS One (2009) 0.88
Isolation of receptor-ligand pairs by capture of long-lived multivalent interaction complexes. Proc Natl Acad Sci U S A (2002) 0.87
Development of a computer-assisted high-throughput screening platform for anti-angiogenic testing. Microvasc Res (2002) 0.86
The heterotrimeric laminin coiled-coil domain exerts anti-adhesive effects and induces a pro-invasive phenotype. PLoS One (2012) 0.85
Gene expression profiling identifies EPHB4 as a potential predictive biomarker in colorectal cancer patients treated with bevacizumab. Med Oncol (2013) 0.83
Virotherapy, gene transfer and immunostimulatory monoclonal antibodies. Oncoimmunology (2012) 0.83
Modulation of the p38 MAPK (mitogen-activated protein kinase) pathway through Bcr/Abl: implications in the cellular response to Ara-C. Biochem J (2005) 0.83
Antibody engineering, virus retargeting and cellular immunotherapy: one ring to rule them all? Curr Gene Ther (2005) 0.82
Antibody gene therapy: getting closer to clinical application? Curr Gene Ther (2013) 0.81
Non-canonical 3'-5' extension of RNA with prebiotically plausible ribonucleoside 2',3'-cyclic phosphates. J Am Chem Soc (2014) 0.81
Enhancement of DNA vaccine potency through linkage of antigen to filamentous bacteriophage coat protein III domain I. Immunology (2006) 0.80
Darwinian chemistry: towards the synthesis of a simple cell. Mol Biosyst (2009) 0.80
The extracellular matrix: a new turn-of-the-screw for anti-angiogenic strategies. Trends Mol Med (2003) 0.80
Translesion synthesis across the (6-4) photoproduct and its Dewar valence isomer by the Y-family and engineered DNA polymerases. Nucleic Acids Symp Ser (Oxf) (2008) 0.80
Origins of life: The cooperative gene. Nature (2012) 0.80
Synthetic polymers and their potential as genetic materials. Bioessays (2012) 0.79
Reversible fluorescence photoswitching in DNA. J Phys Chem B (2012) 0.79
Chemical biotechnology--a marriage of convenience and necessity. Curr Opin Biotechnol (2010) 0.79
Replicating retroviral vectors mediating continuous production and secretion of therapeutic gene products from cancer cells. Cancer Gene Ther (2005) 0.79
Engineering high affinity superantigens by phage display. J Mol Biol (2005) 0.78
The efficacy versus toxicity profile of combination virotherapy and TLR immunotherapy highlights the danger of administering TLR agonists to oncolytic virus-treated mice. Mol Ther (2012) 0.78
Structures of an apo and a binary complex of an evolved archeal B family DNA polymerase capable of synthesising highly cy-dye labelled DNA. PLoS One (2013) 0.78
Basement membrane-rich organoids with functional human blood vessels are permissive niches for human breast cancer metastasis. PLoS One (2013) 0.77
In vivo selection of tumor-specific antibodies. Oncotarget (2013) 0.76
Compartmentalized Self-Tagging for In Vitro-Directed Evolution of XNA Polymerases. Curr Protoc Nucleic Acid Chem (2014) 0.76
Generation of non-permissive basement membranes by anti-laminin antibody fragments produced by matrix-embedded gene-modified cells. Cancer Immunol Immunother (2003) 0.76
Adenovirus E1a protein enhances the cytotoxic effects of the herpes thymidine kinase-ganciclovir system. Cancer Gene Ther (2003) 0.76
Comment on "Production of multivalent protein binders using a self-trimerization collagen-like peptide scaffold". FASEB J (2008) 0.75
Isoguanine and 5-methyl-isocytosine bases, in vitro and in vivo. Chemistry (2015) 0.75
Functionally fused antibodies--a novel adjuvant fusion system. J Immunol Methods (2008) 0.75
Antibody-based antiangiogenic cancer therapy. Expert Opin Ther Targets (2005) 0.75
Selection of 2'-Deoxy-2'-Fluoroarabino Nucleic Acid (FANA) Aptamers that Bind HIV-1 Integrase with Picomolar Affinity. ACS Chem Biol (2019) 0.75
Establishment of an immortalized PARP-1-/- murine endothelial cell line: a new tool to study PARP-1 mediated endothelial cell dysfunction. J Cell Biochem (2005) 0.75